bpc 157 safety studies bpc-157 evidence human clinical trials BPC-157: What you need to know before you BPC-157 Explained: Benefits, Safety &

At the same dose, a 74 kg participant had about 1.4 times the exposure of a 110 kg reference, while a 143 kg participant had about 0.8 times. Weight alone does not set the dose, but it helps explain why the trial mean transfers poorly to bodies outside the studied range

Energy conservation/envelope theory interventions to help patients with myalgic encephalomyelitis/chronic fatigue syndrome

Both tests are performed by accredited third-party laboratories

Whilst injections bypass gut absorption, conditions like active Crohn's disease or coeliac disease may cause increased metabolic demands that could influence how quickly B12 is utilised

doi: 10.1016/j.pain.2008.07.002 94